ribavirin has been researched along with Lymphoma, Non-Hodgkin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Gattei, V; Mazzaro, C; Pozzato, G | 1 |
| Angelidakis, G; Blechacz, B; Economides, MP; Granwehr, BP; Hosry, J; Jiang, Y; Kaseb, A; Kyvernitakis, A; Mahale, P; Miller, E; Naing, A; Raad, II; Samaniego, F; Torres, HA | 1 |
| Aitken, C; Alric, L; Ayuk, F; Bettinger, D; Binder, M; Cornelissen, JJ; de Man, RA; Giordani, MT; Lohse, AW; Mallet, V; Pischke, S; Schlabe, S; Schnitzler, P; Spengler, U; Thimme, R; von Felden, J; Xhaard, A | 1 |
| Ballestri, S; Bertolotti, M; Lonardo, A; Marrazzo, A; Romagnoli, D | 1 |
| Acosta Materan, R; Martín Arribas, MI; Mora Soler, AM; Pérez Corte, D; Revilla Morato, C; Rodríguez Pérez, A; Velasco-Guardado, A | 1 |
| Fragopanagou, E; Giannakoulas, NC; Lampropoulou-Karatza, Ch; Mimidis, K; Pallasopoulou, M; Thomopoulos, K; Tsamandas, AC | 1 |
| Bruno, S; D'Agostino, D; De Renzo, A; La Mura, V; Masarone, M; Perna, F; Persico, M; Romano, M; Torella, R | 1 |
| Comar, C; Dal Maso, L; De Re, V; Festini, G; Mazzaro, C; Pozzato, G; Spina, M; Tirelli, U | 1 |
| Masarone, M; Persico, M | 1 |
| Ermacora, A; Mauro, E; Mazzaro, C; Pedata, M | 1 |
| Duclos-Vallée, JC | 1 |
| Arlt, AC; Dennin, RH; Gause, A; Gross, WL; Gutzeit, O; Lamprecht, P; Lerin-Lozano, C; Merz, H; Peters, SO; Solbach, W; Voswinkel, J | 1 |
| Armor, JF; Fazili, J; Kamble, R; Kern, W; Kharfan-Dabaja, MA; Toubia, N | 1 |
3 review(s) available for ribavirin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
Topics: Antiviral Agents; Cryoglobulinemia; Hepacivirus; Hepatitis C; Humans; Interferons; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Ribavirin | 2021 |
Antiviral therapy: why does it fail in HCV-related chronic hepatitis?
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cryoglobulinemia; Disease Progression; Drug Resistance, Viral; Female; Glomerulonephritis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Ribavirin; RNA, Viral; Sex Factors; Treatment Outcome; Viral Load | 2011 |
[Treatment of hepatitis C virus associated extrahepatic manifestations].
Topics: Antiviral Agents; Autoantibodies; Clinical Enzyme Tests; Clinical Trials as Topic; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferons; Lichen Planus; Lymphoma, Non-Hodgkin; Porphyria Cutanea Tarda; Prospective Studies; Purpura, Thrombocytopenic; Retrospective Studies; Ribavirin; Sjogren's Syndrome; Thyroid Diseases; Time Factors; Transaminases | 2002 |
1 trial(s) available for ribavirin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas.
Topics: Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2009 |
9 other study(ies) available for ribavirin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Topics: Aged; Antiviral Agents; Benzimidazoles; Breast Neoplasms; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluorenes; Head and Neck Neoplasms; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Interferons; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Neoplasms; Polyethylene Glycols; Prospective Studies; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2019 |
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antiviral Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Ribavirin; Rituximab; RNA, Viral; Survival Rate; Young Adult | 2019 |
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Ribavirin; Sofosbuvir; Time Factors; Treatment Failure; Treatment Outcome | 2015 |
[Chronic hepatitis caused by hepatitis E virus and treated with ribavirin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Ascites; Enterobacteriaceae Infections; Female; Hafnia alvei; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Middle Aged; Ribavirin; Rituximab; Transplantation, Autologous | 2016 |
Recurrence of HCV infection in a sustained responder after chemotherapy for non-Hodgkin's lymphoma: successful retreatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin | 2008 |
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Cohort Studies; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Kaplan-Meier Estimate; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult | 2008 |
An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C; Humans; Interferons; Lymphoma, Non-Hodgkin; Remission Induction; Ribavirin; Rituximab | 2012 |
Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Drug Resistance, Neoplasm; Drug Resistance, Viral; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Middle Aged; Recombinant Proteins; Remission Induction; Ribavirin; Rituximab; Vasculitis | 2003 |
Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy.
Topics: Antiviral Agents; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Killer Cells, Natural; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recombinant Proteins; Remission Induction; Ribavirin; Tumor Virus Infections | 2005 |